Search

Your search keyword '"Ortego, N."' showing total 124 results
Start Over Author "Ortego, N."
124 results on '"Ortego, N."'

1. AB0173 MUCOSAL IMMUNE DEFENCE POLYMORPHISMS: RELEVANT PLAYERS IN IGA VASCULITIS?

Author

Pulito-Cueto, V., primary, Remuzgo Martinez, S., additional, Genre Romero, F., additional, Sevilla, B., additional, Ortego, N., additional, Leonardo, M., additional, Peñalba, A., additional, Narváez, J., additional, Martín-Penagos, L., additional, Belmar-Vega, L., additional, Gomez-Fernandez, C., additional, Sebastián Mora-Gil, M., additional, Caminal Montero, L., additional, Collado, P., additional, De Argila, D., additional, Rodriguez-Jimenez, P., additional, Vicente-Rabaneda, E. F., additional, Rubio-Romero, E., additional, Leon Luque, M., additional, Blanco-Madrigal, J. M., additional, Galíndez-Agirregoikoa, E., additional, Martin Ibanez, J., additional, Castañeda, S., additional, González-Gay, M. A., additional, Blanco, R., additional, and López-Mejías, R., additional

Published
2023
Full Text
View/download PDF

4. OP0102 IDENTIFICATION OF NEW RISK LOCI AND PATHWAYS INVOLVED IN GCA PATHOGENESIS BY A GENOME-WIDE STUDY

Author

Borrego-Yaniz, G., primary, Ortiz-Fernández, L., additional, Kerick, M., additional, Madrid-Paredes, A., additional, Vaglio, A., additional, Hernández-Rodríguez, J., additional, Mackie, S., additional, Castañeda, S., additional, Solans-Laqué, R., additional, Mestre, J., additional, Dasgupta, B., additional, Watts, R., additional, Khalidi, N., additional, Langford, C., additional, Ytterberg, S. R., additional, Beretta, L., additional, Govoni, M., additional, Emmi, G., additional, Cimmino, M. A., additional, Witte, T., additional, Neumann, T., additional, Holle, J., additional, Schönau, V., additional, Pugnet, G., additional, Papo, T., additional, Haroche, J., additional, Mahr, A., additional, Mouthon, L., additional, Molberg, Ø., additional, Diamantopoulos, A., additional, Voskuyl, A., additional, Daikeler, T., additional, Berger, C., additional, Molloy, E., additional, Blockmans, D., additional, Consortium, U. G., additional, Gca Consortium, I., additional, Ortego, N., additional, Brouwer, E., additional, Lamprecht, P., additional, Klapa, S., additional, Salvarani, C., additional, Merkel, P. A., additional, Cid, M. C., additional, González-Gay, M. A., additional, Morgan, A., additional, Martin Ibanez, J., additional, and Márquez, A., additional

Published
2023
Full Text
View/download PDF

5. AB0166 IGAV AND IGAN: A SINGLE ENTITY REGARDING CD40, BLK AND BANK1 POLYMORPHISMS

Author

Pulito-Cueto, V., primary, Genre Romero, F., additional, Remuzgo Martinez, S., additional, Sevilla, B., additional, Ortego, N., additional, Leonardo, M., additional, Peñalba, A., additional, Narváez, J., additional, Martín-Penagos, L., additional, Belmar-Vega, L., additional, Gomez-Fernandez, C., additional, Sebastián Mora-Gil, M., additional, Caminal Montero, L., additional, Collado, P., additional, Fernandez-Nebro, A., additional, Diaz-Cordobes, G., additional, Cigarrán, S., additional, Calviño, J., additional, Cobelo, C., additional, De Argila, D., additional, Sanchez Perez, J., additional, Uriarte-Ecenarro, M., additional, Rubio-Romero, E., additional, Leon Luque, M., additional, Blanco-Madrigal, J. M., additional, Galíndez-Agirregoikoa, E., additional, Martin Ibanez, J., additional, Castañeda, S., additional, González-Gay, M. A., additional, Blanco, R., additional, and López-Mejías, R., additional

Published
2023
Full Text
View/download PDF

6. POS1276 A SINGLE CELL TRANSCRIPTOMIC ANALYSIS REVEALS A PRO-INFLAMMATORY PROFILE IN PERIPHERAL BLOOD CD14+ MONOCYTES OF SYSTEMIC SCLEROSIS PATIENTS

Author

Villanueva-Martin, G., primary, Acosta-Herrera, M., additional, Carmona, E., additional, Kerick, M., additional, Ortego, N., additional, Callejas-Rubio, J. L., additional, Mages, N., additional, Klages, S., additional, Boerno, S., additional, Timmermann, B., additional, Bossini-Castillo, L., additional, and Martin Ibanez, J., additional

Published
2023
Full Text
View/download PDF

8. AB0145 IgA VASCULITIS AND IgA NEPHROPATHY SHARE A SIMILAR IL33-IL1RL1 ASSOCIATION PATTERN

Author

Prieto-Peña, D., primary, Remuzgo Martinez, S., additional, Genre, F., additional, Pulito-Cueto, V., additional, Atienza-Mateo, B., additional, Sevilla, B., additional, Llorca, J., additional, Ortego, N., additional, Leonardo, M., additional, Peñalba, A., additional, Martín-Penagos, L., additional, Miranda Fillloy, J. A., additional, Narváez, J., additional, Caminal Montero, L., additional, Collado, P., additional, Fernandez-Nebro, A., additional, Díaz-Cordoves, G., additional, Cigarrán, S., additional, Calviño, J., additional, Cobelo, C., additional, Quiroga Colino, P., additional, Sanchez Perez, J., additional, Rubio-Romero, E., additional, Leon Luque, M., additional, Blanco-Madrigal, J. M., additional, Galíndez-Agirregoikoa, E., additional, Gualillo, O., additional, Martin Ibanez, J., additional, Castañeda, S., additional, Blanco, R., additional, González-Gay, M. A., additional, and López-Mejías, R., additional

Published
2022
Full Text
View/download PDF

10. POS0828 BIOLOGIC THERAPY IN REFRACTORY PARENCHYMAL AND NON-PARENCHYMAL NEUROBEHÇET DISEASE: NATIONAL MULTICENTER STUDY

Author

Herrero-Morant, A., primary, Martín-Varillas, J. L., additional, Castañeda, S., additional, Maiz-Alonso, O., additional, Sanchez-Martin, J., additional, Ortego, N., additional, Raya, E., additional, Prior-Español, Á., additional, Moriano, C., additional, Melero, R., additional, Graña, J., additional, Urruticoechea-Arana, A., additional, Ramos Calvo, A., additional, Loredo Martínez, M., additional, Salgado-Pérez, E., additional, Sivera, F., additional, Torre-Salaberri, I., additional, Narváez, J., additional, Andréu Sánchez, J. L., additional, Martínez González, O., additional, Gómez de la Torre, R., additional, Fernández, S., additional, Romero-Yuste, S., additional, Gonzalez-Mazon, I., additional, Álvarez-Reguera, C., additional, Martínez-López, D., additional, Hernández, J. L., additional, González-Gay, M. Á., additional, and Blanco, R., additional

Published
2022
Full Text
View/download PDF

11. OP0231 MASS CYTOMETRY DATA RECLASSIFY SYSTEMIC AUTOIMMUNE DISEASE PATIENTS IN PHENOTYPICALLY DISTINCTIVE GROUPS

Author

Rybakowska, P., primary, van Gassen, S., additional, Perez-Sanchez, C., additional, Ibañez-Costa, A., additional, Varela, N., additional, Ortega Castro, R., additional, Fernández-Roldán, C., additional, Jiménez-Moleón, I., additional, Ortego, N., additional, Raya, E., additional, Aguilar Quesada, R., additional, Lopez-Pedrera, C., additional, Collantes Estevez, E., additional, Saeys, Y., additional, Alarcon-Riquelme, M., additional, and Marañón, C., additional

Published
2022
Full Text
View/download PDF

12. AB0146 BAFF, APRIL y BAFFR: DIFFERENTIAL BIOMARKERS BETWEEN IgA VASCULITIS AND IgA NEPHROPATHY?

Author

Prieto-Peña, D., primary, Genre, F., additional, Remuzgo Martinez, S., additional, Pulito-Cueto, V., additional, Atienza-Mateo, B., additional, Sevilla, B., additional, Llorca, J., additional, Ortego, N., additional, Leonardo, M., additional, Peñalba, A., additional, Martín-Penagos, L., additional, Miranda Fillloy, J. A., additional, Narváez, J., additional, Caminal Montero, L., additional, Collado, P., additional, Fernandez-Nebro, A., additional, Díaz-Cordoves, G., additional, Cigarrán, S., additional, Calviño, J., additional, Cobelo, C., additional, De Argila, D., additional, Vicente-Rabaneda, E. F., additional, Rubio-Romero, E., additional, Leon Luque, M., additional, Blanco-Madrigal, J. M., additional, Galíndez-Agirregoikoa, E., additional, Gualillo, O., additional, Martin Ibanez, J., additional, Castañeda, S., additional, Blanco, R., additional, González-Gay, M. A., additional, and López-Mejías, R., additional

Published
2022
Full Text
View/download PDF

13. Biologic therapy in refractory neurobehcet's disease: a multicentre study of 41 patients and literature review

Author

Herrero-Morant, A, Martin-Varillas, JL, Castaneda, S, Maiz, O, Sanchez, J, Ortego, N, Raya, E, Prior-Espanol, A, Moriano, C, Melero-Gonzalez, RB, Grana-Gil, J, Urruticoechea-Arana, A, Ramos-Calvo, A, Loredo-Martinez, M, Salgado-Perez, E, Sivera, F, Torre, I, Narvaez, J, Andreu, JL, Martinez-Gonzalez, O, Gomez-de la Torre, R, Fernandez-Aguado, S, Romero-Yuste, S, Gonzalez-Mazon, I, Alvarez-Reguera, C, Hernandez, JL, Gonzalez-Gay, MA, and Blanco, R

Subjects
tocilizumab, rituximab, Neurobehcet, biologic therapy, anti-TNF, ustekinumab, canakinumab, anakinra
Abstract

Objectives To assess efficacy and safety of biologic therapy (BT) in neurobehcet's disease (NBD) refractory to glucocorticoids and at least one conventional immunosuppressive drug. Methods Open-label, national, multicentre study. NBD diagnosis was based on the International Consensus Recommendation criteria. Outcome variables were efficacy and safety. Main efficacy outcome was clinical remission. Other outcome variables analysed were glucocorticoid-sparing effect and improvement in laboratory parameters. Results We studied 41 patients [21 women; age 40.6 (10.8) years]. Neurological damage was parenchymal (n = 33, 80.5%) and non-parenchymal (n = 17, 41.5%). First BTs used were infliximab (n = 19), adalimumab (n = 14), golimumab (n = 3), tocilizumab (n = 3) and etanercept (n = 2). After 6 months of BT, neurological remission was complete (n = 23, 56.1%), partial (n = 15, 37.6%) and no response (n = 3, 7.3%). In addition, median (IQR) dose of oral prednisone decreased from 60 (30-60) mg/day at the initial visit to 5 (3.8-10) mg/day after 6 months (P < 0.001). It was also the case for mean erythrocyte sedimentation rate [31.5 (25.6)-15.3 (11.9) mm/1st h, P = 0.011] and median (IQR) C-reactive protein [1.4 (0.2-12.8) to 0.3 (0.1-3) mg/dl, P = 0.001]. After a mean follow-up of 57.5 months, partial or complete neurological remission persisted in 37 patients (90.2%). BT was switched in 22 cases (53.6%) due to inefficacy (n = 16) or adverse events (AEs) (n = 6) and discontinued due to complete prolonged remission (n = 3) or severe AE (n = 1). Serious AEs were observed in two patients under infliximab treatment. Conclusions BT appears to be effective and relatively safe in refractory NBD.

Published
2022

15. HIGH DOSE INTRAVENOUS METHYLPREDNISOLONE INDUCES RAPID IMPROVEMENT OF VISUAL ACUITY IN NON-INFECTIOUS UVEITIS OF DIFFERENT IMMUNE MEDIATED INFLAMMATORY DISEASES

Author

Vegas-Revenga N, Martin-Varillas J, Calvo-Rio V, Gonzalez-Mazon I, Sanchez-Bilbao L, Beltran E, Fonollosa A, Maiz-Alonso O, Blanco A, Cordero-Coma M, Ortego N, Torre-Salaberri I, Francisco F, Fernandez S, Esteban-Ortega M, Diaz-Llopis M, Canal J, Ventosa J, Demetrio-Pablo R, Dominguez L, Agudo-Bilbao M, Castaneda S, Ferraz-Amaro I, Gonzalez-Gay M, and Blanco R

Published
2021

17. RAPID IMPROVEMENT IN CYSTOID MACULAR EDEMA WITH HIGH DOSE INTRAVENOUS METHYLPREDNISOLONE IN NON-INFECTIOUS UVEITIS OF DIFFERENT IMMUNE MEDIATED INFLAMMATORY DISEASES

Author

Vegas-Revenga N, Martin-Varillas J, Calvo-Rio V, Gonzalez-Mazon I, Sanchez-Bilbao L, Beltran E, Fonollosa A, Maiz-Alonso O, Blanco A, Cordero-Coma M, Ortego N, Torre-Salaberri I, Francisco F, Fernandez S, Esteban-Ortega M, Diaz-Llopis M, Canal J, Ventosa J, Demetrio-Pablo R, Dominguez L, Agudo-Bilbao M, Castaneda S, Ferraz-Amaro I, Gonzalez-Gay M, and Blanco R

Published
2021

18. BIOLOGICAL THERAPY IN REFRACTORY NEUROBEHCET'S DISEASE. MULTICENTER STUDY OF 42 PATIENTS

Author

Herrero-Morant, A, Martin-Varillas, JL, Calvo-Rio, V, Castaneda, S, Maiz, O, Blanco, A, Sanchez, J, Ortego, N, Raya, E, Brandy-Garcia, AM, Olive-Marques, A, Prior-Espanol, A, Moriano, C, Diez, E, Melero, R, Gil, JEG, Seijas-Lopez, A, Urruticoechea-Arana, A, Ramos-Calvo, A, Delgado-Beltran, C, Loredo-Martinez, M, Salgado, E, Sivera, F, Torre, I, Narvaez, J, Andreu, JL, Martinez, O, de la Torre, RG, Fernandez-Aguado, S, Romero-Yuste, S, Espinosa, G, Gonzalez-Gay, MA, and Blanco, R

Published
2021

19. Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature review

Author

Prieto-Pena D, Bernabeu P, Vela P, Narvaez J, Fernandez-Lopez J, Freire-Gonzalez M, Gonzalez-Alvarez B, Solans-Laque R, Rubio J, Ortego N, Fernandez-Diaz C, Rubio E, Garcia-Morillo S, Minguez M, Fernandez-Carballido C, de Miguel E, Melchor S, Salgado E, Bravo B, Romero-Yuste S, Salvatierra J, Hidalgo C, Manrique S, Romero-Gomez C, Moya P, Alvarez-Rivas N, Mendizabal J, Ortiz-Sanjuan F, de Pedro I, Alonso-Valdivielso J, Perez-Sanchez L, Roldan R, Fernandez-Llanio N, de la Torre R, Suarez S, Cabrera M, Sanchez M, Loricera J, Atienza-Mateo B, Castaneda S, Gonzalez-Gay M, and Blanco R

Subjects
Takayasu's arteritis, cDMARDs, biological therapy, Caucasian, Tocilizumab
Abstract

Objective: To assess the efficacy and safety of tocilizumab (TCZ) in Caucasian patients with refractory Takayasu's arteritis (TAK) in clinical practice. Methods: A multicenter study of Caucasian patients with refractory TAK who received TCZ. The outcome variables were remission, glucocorticoid-sparing effect, improvement in imaging techniques, and adverse events. A comparative study between patients who received TCZ as monotherapy (TCZ(MONO)) and combined with conventional disease modifying anti-rheumatic drugs (cDMARDs) (TCZ(COMBO)) was performed. Results: The study comprised 54 patients (46 women/8 men) with a median [interquartile range (IQR)] age of 42.0 (32.5-50.5) years. TCZ was started after a median (IQR) of 12.0 (3.0-31.5) months since TAK diagnosis. Remission was achieved in 12/54 (22.2%), 19/49 (38.8%), 23/44 (52.3%), and 27/36 (75%) patients at 1, 3, 6, and 12 months, respectively. The prednisone dose was reduced from 30.0 mg/day (12.5-50.0) to 5.0 (0.0-5.6) mg/day at 12 months. An improvement in imaging findings was reported in 28 (73.7%) patients after a median (IQR) of 9.0 (6.0-14.0) months. Twenty-three (42.6%) patients were on TCZ(MONO) and 31 (57.4%) on TCZ(COMBO): MTX (n = 28), cyclosporine A (n = 2), azathioprine (n = 1). Patients on TCZ(COMBO) were younger [38.0 (27.0-46.0) versus 45.0 (38.0-57.0)] years; difference (diff) [95% confidence interval (CI) = -7.0 (-17.9, -0.56] with a trend to longer TAK duration [21.0 (6.0-38.0) versus 6.0 (1.0-23.0)] months; diff 95% CI = 15 (-8.9, 35.5), and higher c-reactive protein [2.4 (0.7-5.6) versus 1.3 (0.3-3.3)] mg/dl; diff 95% CI = 1.1 (-0.26, 2.99). Despite these differences, similar outcomes were observed in both groups (log rank p = 0.862). Relevant adverse events were reported in six (11.1%) patients, but only three developed severe events that required TCZ withdrawal. Conclusion: TCZ in monotherapy, or combined with cDMARDs, is effective and safe in patients with refractory TAK of Caucasian origin.

Published
2021

20. TOCILIZUMAB FOR TAKAYASU ARTERITIS: MULTICENTER STUDY OF 54 WHITE PATIENTS

Author

Prieto-Pena D, Bernabeu P, Vela-Casasempere P, Narvaez J, Fernandez-Lopez C, Gonzalez M, Gonzalez-Alvarez B, Solans-Laque R, Callejas-Rubio J, Ortego N, Fernandez-Diaz C, Romero E, Morillo S, Minguez M, Fernandez-Carballido C, De Miguel E, Melchor S, Salgado-Perez E, Bravo B, Romero-Yuste S, Salvatierra J, Hidalgo C, Arija S, Romero-Gomez C, Moya P, Alvarez-Rivas N, Mendizabal J, Sanjuan F, de Pedro I, Valdivieso J, Laura P, Rosa R, Fernandez-Llanio N, de la Torre R, Suarez S, Montesa M, Sanchez M, Loricera J, Atienza-Mateo B, Castaneda S, Gonzalez-Gay M, and Blanco R

Published
2021

21. Multiple vertebral fractures after suspension of denosumab. A series of 56 cases

Author

Sosa-Henriquez M, Torregrosa O, Deniz A, Saavedra P, Ortego N, Turrion A, Castrillon J, Diaz-Curiel M, Gomez-Alonso C, Martinez G, Blazquez J, Olmos-Martinez J, Etxebarria I, Caeiro J, and Mora-Pena D

Abstract

Background Denosumab is a monoclonal antibody approved for the treatment of postmenopausal osteoporosis. The withdrawal of denosumab produces an abrupt loss of bone mineral density and may cause multiple vertebral fractures (MVF). Objective The objective of this study is to study the clinical, biochemical, and densitometric characteristics in a large series of postmenopausal women who suffered MVF after denosumab withdrawal. Likewise, we try to identify those factors related to the presence of a greater number of vertebral fractures (VF). Patients and Methods Fifty-six patients (54 women) who suffered MVF after receiving denosumab at least for three consecutive years and abruptly suspended it. A clinical examination was carried out. Biochemical bone remodelling markers (BBRM) and bone densitometry at the lumbar spine and proximal femur were measured. VF were diagnosed by magnetic resonance imaging MRI, X-ray, or both at dorsal and lumbar spine. Results Fifty-six patients presented a total of 192 VF. 41 patients (73.2%) had not previously suffered VF. After discontinuation of the drug, a statistically significant increase in the BBRM was observed. In the multivariate analysis, only the time that denosumab was previously received was associated with the presence of a greater number of VF (P = .04). Conclusions We present the series with the largest number of patients collected to date. 56 patients accumulated 192 new VF. After the suspension of denosumab and the production of MVF, there was an increase in the serum values of the BBRM. The time of denosumab use was the only parameter associated with a greater number of fractures.

Published
2021

23. AB0396 RAPID IMPROVEMENT IN CYSTOID MACULAR EDEMA WITH HIGH DOSE INTRAVENOUS METHYLPREDNISOLONE IN NON-INFECTIOUS UVEITIS OF DIFFERENT IMMUNE MEDIATED INFLAMMATORY DISEASES

Author

Vegas-Revenga, N., primary, Martín-Varillas, J. L., additional, Calvo-Río, V., additional, González-Mazón, I., additional, Sanchez-Bilbao, L., additional, Beltrán, E., additional, Fonollosa, A., additional, Maiz-Alonso, O., additional, Blanco, A., additional, Cordero-Coma, M., additional, Ortego, N., additional, Torre-Salaberri, I., additional, Francisco, F., additional, Muñoz Fernandez, S., additional, Esteban-Ortega, M. D. M., additional, Díaz-Llopis, M., additional, Cañal, J., additional, Ventosa, J. A., additional, Demetrio-Pablo, R., additional, Domínguez, L., additional, Agudo-Bilbao, M., additional, Castañeda, S., additional, Ferraz-Amaro, I., additional, González-Gay, M. A., additional, and Blanco, R., additional

Published
2021
Full Text
View/download PDF

24. POS1409 AUTOMATED DETECTION OF SCLERODERMIFORM PATTERNS USING CAPILLARY.IO

Author

Ramos, E., primary, Guillén-Del-Castillo, A., additional, Simeón-Aznar, C. P., additional, Gracia Tello, B., additional, Fonollosa Pla, V., additional, Selva-O’callaghan, A., additional, Sáez-Comet, L., additional, Martínez Robles, E., additional, Rios, J. J., additional, Espinosa, G., additional, Todolí Parra, J. A., additional, Callejas-Rubio, J. L., additional, Ortego, N., additional, Marí-Alfonso, B., additional, Freire, M., additional, and Fanlo, P., additional

Published
2021
Full Text
View/download PDF

25. POS1408 REPRODUCIBILITY OF A NEW AUTOMATIC SYSTEM (CAPILLARY.IO) IN THE ANALYSIS OF NAILFOLD CAPILLAROSCOPY IMAGES

Author

Gracia Tello, B., primary, Ramos, E., additional, Simeón-Aznar, C. P., additional, Fonollosa Pla, V., additional, Guillén-Del-Castillo, A., additional, Selva-O’callaghan, A., additional, Sáez-Comet, L., additional, Martínez Robles, E., additional, Rios, J. J., additional, Espinosa, G., additional, Todolí Parra, J. A., additional, Callejas-Rubio, J. L., additional, Ortego, N., additional, Marí-Alfonso, B., additional, Freire, M., additional, and Fanlo, P., additional

Published
2021
Full Text
View/download PDF

26. POS0113 BAFF-APRIL-BAFFR PATHWAY ON THE PATHOGENESIS OF IMMUNOGLOBULIN-A VASCULITIS

Author

Prieto-Peña, D., primary, Remuzgo Martinez, S., additional, Genre, F., additional, Pulito-Cueto, V., additional, Atienza-Mateo, B., additional, Sevilla, B., additional, Llorca, J., additional, Ortego, N., additional, Lera-Gómez, L., additional, Leonardo, M., additional, Peñalba, A., additional, Narváez, J., additional, Martín-Penagos, L., additional, Miranda-Filloy, J. A., additional, Caminal Montero, L., additional, Collado, P., additional, Sanchez Perez, J., additional, De Argila, D., additional, Rubio-Romero, E., additional, Leon Luque, M., additional, Blanco-Madrigal, J. M., additional, Galindez, E., additional, Martin Ibanez, J., additional, Castañeda, S., additional, Blanco, R., additional, González-Gay, M. A., additional, and López-Mejías, R., additional

Published
2021
Full Text
View/download PDF

31. AB0366 TOCILIZUMAB FOR TAKAYASU ARTERITIS: MULTICENTER STUDY OF 54 WHITE PATIENTS

Author

Prieto-Peña, D., primary, Bernabéu, P., additional, Vela-Casasempere, P., additional, Narváez, J., additional, Fernández-López, C., additional, Freire González, M., additional, González-Alvarez, B., additional, Solans-Laqué, R., additional, Callejas-Rubio, J. L., additional, Ortego, N., additional, Fernández-Díaz, C., additional, Rubio Romero, E., additional, García Morillo, S., additional, Minguez, M., additional, Fernández-Carballido, C., additional, De Miguel, E., additional, Melchor, S., additional, Salgado-Pérez, E., additional, Bravo, B., additional, Romero-Yuste, S., additional, Salvatierra, J., additional, Hidalgo, C., additional, Manrique Arija, S., additional, Romero-Gómez, C., additional, Moya, P., additional, Alvarez-Rivas, N., additional, Mendizabal, J., additional, Ortiz Sanjuan, F. M., additional, Pérez de Pedro, I., additional, Alonso Valdivieso, J. L., additional, Laura, P. S., additional, Rosa, R. M., additional, Fernández-Llanio, N., additional, Gómez de la Torre, R., additional, Suarez, S., additional, Montesa, M. J., additional, Delgado Sanchez, M., additional, Loricera, J., additional, Atienza-Mateo, B., additional, Castañeda, S., additional, González-Gay, M. A., additional, and Blanco, R., additional

Published
2021
Full Text
View/download PDF

32. POS1371 BIOLOGICAL THERAPY IN REFRACTORY NEUROBEHÇET’S DISEASE. MULTICENTER STUDY OF 42 PATIENTS

Author

Herrero-Morant, A., primary, Martín-Varillas, J. L., additional, Castañeda, S., additional, González-Mazón, I., additional, Maiz, O., additional, Blanco, A., additional, Sánchez, J., additional, Ortego, N., additional, Raya, E., additional, Olive, A., additional, Brandy-Garcia, A., additional, Prior-Español, Á., additional, Moriano, C., additional, Diez Alvarez, E., additional, Melero, R., additional, Graña, J., additional, Seijas-López, Á., additional, Urruticoechea-Arana, A., additional, Ramos Calvo, A., additional, Delgado Beltrán, C., additional, Loredo Martínez, M., additional, Salgado-Pérez, E., additional, Sivera, F., additional, Torre-Salaberri, I., additional, Narváez, J., additional, Andréu Sánchez, J. L., additional, Martínez González, O., additional, Gómez de la Torre, R., additional, Fernández, S., additional, Romero-Yuste, S., additional, Espinosa, G., additional, González-Gay, M. Á., additional, and Blanco, R., additional

Published
2021
Full Text
View/download PDF

33. AB0096 IGA VASCULITIS AND IGA NEPHROPATHY SHARE A SIMILAR IL17A ASSOCIATION PATTERN

Author

Prieto-Peña, D., primary, Genre, F., additional, Remuzgo Martinez, S., additional, Pulito-Cueto, V., additional, Atienza-Mateo, B., additional, Sevilla, B., additional, Llorca, J., additional, Ortego, N., additional, Lera-Gómez, L., additional, Leonardo, M., additional, Peñalba, A., additional, Martín-Penagos, L., additional, Miranda-Filloy, J. A., additional, Narváez, J., additional, Caminal Montero, L., additional, Collado, P., additional, Fernandez-Nebro, A., additional, Díaz-Cordoves, G., additional, Cigarrán, S., additional, Calviño, J., additional, Cobelo, C., additional, Sanchez Perez, J., additional, De Argila, D., additional, Rubio-Romero, E., additional, Leon Luque, M., additional, Blanco-Madrigal, J. M., additional, Galindez, E., additional, Martin Ibanez, J., additional, Castañeda, S., additional, Blanco, R., additional, González-Gay, M. A., additional, and López-Mejías, R., additional

Published
2021
Full Text
View/download PDF

34. AB0771 HIGH DOSE INTRAVENOUS METHYLPREDNISOLONE INDUCES RAPID IMPROVEMENT OF VISUAL ACUITY IN NON-INFECTIOUS UVEITIS OF DIFFERENT IMMUNE MEDIATED INFLAMMATORY DISEASES

Author

Vegas-Revenga, N., primary, Martín-Varillas, J. L., additional, Calvo-Río, V., additional, González-Mazón, I., additional, Sanchez-Bilbao, L., additional, Beltrán, E., additional, Fonollosa, A., additional, Maiz-Alonso, O., additional, Blanco, A., additional, Cordero-Coma, M., additional, Ortego, N., additional, Torre-Salaberri, I., additional, Francisco, F., additional, Muñoz Fernandez, S., additional, Esteban-Ortega, M. D. M., additional, Díaz-Llopis, M., additional, Cañal, J., additional, Ventosa, J. A., additional, Demetrio-Pablo, R., additional, Domínguez, L., additional, Agudo-Bilbao, M., additional, Castañeda, S., additional, Ferraz-Amaro, I., additional, González-Gay, M. A., additional, and Blanco, R., additional

Published
2021
Full Text
View/download PDF

35. SAT0523 BIOLOGICAL THERAPY IN REFRACTORY ATYPICAL OPTIC NEURITIS. MULTICENTER STUDY

Author

Herrero Morant, A., primary, Álvarez Reguera, C., additional, Calvo del Rio, V., additional, Maíz Alonso, O., additional, Blanco, A., additional, Narváez, J., additional, Castañeda, S., additional, Vicente, E., additional, Romero-Yuste, S., additional, Demetrio-Pablo, R., additional, Urruticoechea-Arana, A., additional, García Serrano, J. L., additional, Callejas Rubio, J. L., additional, Ortego, N., additional, Sánchez, J., additional, Estrada, P., additional, Rua-Figueroa, I., additional, Martínez-López, D., additional, Martín-Varillas, J. L., additional, González-Gay, M. Á., additional, and Blanco, R., additional

Published
2020
Full Text
View/download PDF

36. THU0297 SERIOUS INFECTIONS IN 134 PATIENTS WITH GIANT CELL ARTERITIS WITH TOCILIZUMAB IN CLINICAL PRACTICE. FREQUENCY, TYPE AND CLINICAL ASSOCIATIONS

Author

Calderón-Goercke, M., primary, Prieto-Peña, D., additional, Castañeda, S., additional, Moriano, C., additional, Becerra-Fernández, E., additional, Revenga, M., additional, Alvarez-Rivas, N., additional, Galisteo, C., additional, Prior-Español, Á., additional, Galindez, E., additional, Hidalgo, C., additional, Manrique Arija, S., additional, De Miguel, E., additional, Salgado-Pérez, E., additional, Aldasoro, V., additional, Villa-Blanco, I., additional, Romero-Yuste, S., additional, Narváez, J., additional, Gomez-Arango, C., additional, Perez-Pampín, E., additional, Melero, R., additional, Sivera, F., additional, Fernández-Díaz, C., additional, Olive, A., additional, Álvarez del Buergo, M., additional, Marena Rojas, L., additional, Fernández-López, C., additional, Navarro, F., additional, Raya, E., additional, Arca, B., additional, Solans-Laqué, R., additional, Conesa, A., additional, Vázquez, C., additional, Román-Ivorra, J. A., additional, Lluch, P., additional, Vela-Casasempere, P., additional, Torres-Martín, C., additional, Nieto, J. C., additional, Ordas-Calvo, C., additional, Luna-Gomez, C., additional, Toyos Sáenz de Miera, F. J., additional, Fernández-Llanio, N., additional, García, A., additional, González-Vela, C., additional, García-Fernández, J., additional, Vicente-Gómez, P., additional, García-Manzanares, Á., additional, Ortego, N., additional, Ortiz-Sanjuán, F., additional, Corteguera, M., additional, Hernández, J. L., additional, González-Gay, M. A., additional, and Blanco, R., additional

Published
2020
Full Text
View/download PDF

37. SAT0322 PREVALENCE AND RISK FACTORS FOR LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN SYSTEMIC SCLEROSIS: RESULTS FROM RESCLE REGISTRY

Author

González, A., primary, Patier, J. L., additional, López-Rodríguez, M., additional, Guillén del Castillo, A., additional, Rubio-Rivas, M., additional, Argibay, A., additional, Marí-Alfonso, B., additional, Chamorro, A. J., additional, Madroñero-Vuelta, A. B., additional, Callejas-Moraga, E. L., additional, González-Echávarri, C., additional, Ortego, N., additional, Fonollosa-Pla, V., additional, Simeón-Aznar, C. P., additional, and Autoimmune Diseases Study Group (Geas), O. B. O. R. I., additional

Published
2020
Full Text
View/download PDF

38. SAT0270 TOCILIZUMAB IN REFRACTORY TAKAYASU ARTERITIS. OPEN-LABEL NATIONAL MULTICENTER STUDY OF 53 PATIENTS OF CLINICAL PRACTICE

Author

Prieto-Peña, D., primary, Calderón-Goercke, M., additional, Bernabéu, P., additional, Vela-Casasempere, P., additional, Narváez, J., additional, Fernández-López, C., additional, Freire González, M., additional, González-Alvarez, B., additional, Solans-Laqué, R., additional, Callejas-Rubio, J. L., additional, Ortego, N., additional, Fernández-Díaz, C., additional, Rubio Romero, E., additional, García Morillo, S., additional, Minguez, M., additional, Fernández-Carballido, C., additional, De Miguel, E., additional, Melchor, S., additional, Salgado-Pérez, E., additional, Bravo, B., additional, Romero-Yuste, S., additional, Salvatierra, J., additional, Hidalgo, C., additional, Manrique Arija, S., additional, Romero-Gómez, C., additional, Moya, P., additional, Alvarez-Rivas, N., additional, Mendizabal, J., additional, Ortiz Sanjuan, F. M., additional, Pérez de Pedro, I., additional, Loricera, J., additional, Castañeda, S., additional, González-Gay, M. A., additional, and Blanco, R., additional

Published
2020
Full Text
View/download PDF

39. SAT0316 ANTI-PM/SCL ANTIBODIES IN SYSTEMIC SCLEROSIS: CLINICAL ASSOCIATIONS IN THE RESCLE COHORT

Author

Iniesta-Arandia, N., primary, Espinosa, G., additional, Guillen del Castillo, A., additional, Tolosa, C., additional, Lledó, G. M., additional, Colunga Argüelles, D., additional, González-Echávarri, C., additional, Sáez-Comet, L., additional, Ortego, N., additional, Vargas-Hitos, J. A., additional, Rubio-Rivas, M., additional, Freire, M., additional, Rios, J. J., additional, Rodriguez-Carballeira, M., additional, Trapiella Martínez, L., additional, Fonollosa Pla, V., additional, and Simeón-Aznar, C. P., additional

Published
2020
Full Text
View/download PDF

40. AB0011 INFLUENCE OF IL17A GENE ON THE PATHOGENESIS OF IMMUNOGLOBULIN-A VASCULITIS

Author

Genre, F., primary, Remuzgo Martinez, S., additional, Pulito-Cueto, V., additional, Prieto-Peña, D., additional, Atienza-Mateo, B., additional, Sevilla, B., additional, Llorca, J., additional, Ortego, N., additional, Lera-Gómez, L., additional, Leonardo, M., additional, Peñalba, A., additional, Cabero, M. J., additional, Martín-Penagos, L., additional, Miranda-Filloy, J. A., additional, Navas Parejo, A., additional, De Argila, D., additional, Aragües, M., additional, Rubio-Romero, E., additional, Leon Luque, M., additional, Blanco-Madrigal, J. M., additional, Galindez, E., additional, Martin Ibanez, J., additional, Castañeda, S., additional, Blanco, R., additional, González-Gay ,,, M. A., additional, and López-Mejías, R., additional

Published
2020
Full Text
View/download PDF

41. AB0012 ROLE OF IRF5 GENE ON THE PATHOGENESIS OF IMMUNOGLOBULIN-A VASCULITIS

Author

Remuzgo Martinez, S., primary, Genre, F., additional, Pulito-Cueto, V., additional, Prieto-Peña, D., additional, Atienza-Mateo, B., additional, Sevilla, B., additional, Llorca, J., additional, Ortego, N., additional, Lera-Gómez, L., additional, Leonardo, M., additional, Peñalba, A., additional, Cabero, M. J., additional, Martín-Penagos, L., additional, Miranda-Filloy, J. A., additional, Navas Parejo, A., additional, Sanchez Perez, J., additional, Aragües, M., additional, Rubio, E., additional, Leon Luque, M., additional, Blanco-Madrigal, J. M., additional, Galindez, E., additional, Martin Ibanez, J., additional, Castañeda, S., additional, Blanco, R., additional, González-Gay ,,, M. A., additional, and López-Mejías, R., additional

Published
2020
Full Text
View/download PDF

42. LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients

Author

Castellvi, I, Eguiluz, S, Escudero-Contreras, A, Rios, JJ, Calvo-Alen, J, Callejas-Rubio, JL, De la Puente, C, Simeon, CP, Narvaez, FJ, Espinosa, G, Carreira, PE, Rubio-Rivas, M, Alegre, JJ, Roman-Ivorra, JA, Fonollosa, V, de la Iglesia, BA, Ajo, JB, Perdomo, DB, Catalan, EB, Otano, JB, Rodriguez, JSB, Freire, MC, Alutiz, C, Montes, IC, Lecumberri, MC, Monsalvo, RD, Alvarez, ED, Dubuc, CAE, Arberas, MVE, Mateo, PF, Dapena, FDF, Gonzalez, MF, Aparicio, AG, Hernandez, FJG, de Salazar, JG, Nieto, JAG, Gil, JG, Guillen-Del-Castillo, A, Hidalgo, JI, Mas, TJ, Pineiro, MCL, Longo, FJL, Nunez, LML, Ballve, AM, Fernandez-Cid, CM, Miguelez, R, Rodriguez, MAM, Morales, JM, Morla, RM, Bruno, SO, Marques, AO, Laraundogoitia, EO, Ortego, N, Santamaria, VO, Conesa, MPP, Sandoval, TP, Simon, AP, Lozano, BR, Cid, AR, Comet, LS, Osorio, JS, Lopez, AS, Soler, GS, Guevara, MS, Parra, JAT, Ramos, CT, Beltran, JT, Montanez, JMU, and Rabaneda, EV

Subjects
Quality of life, Scleroderma and related disorders, Disability evaluation, Human activities, Hand
Abstract

The objective of this study was to evaluate the impact of digital ulcers (DUs) in daily life of systemic sclerosis (SSc) Spanish patients. We developed a multicenter observational study to compare functional disability in SSc patients with active DUs vs. those without DUs. An additional correlation between perception of patients and physicians on disability due to DUs was performed. A total of 199 patients were enrolled, 70 (35%) with DUs. Patients with DUs were younger (48 vs. 58 years; p < 0.001) and had more frequently the diffuse subtype of SSc (45 vs. 24%; p = 0.004) than patients without DUs. Patients with DUs showed significantly higher scores in the Cochin Hand Function Scale overall (p < 0.002) and for each of its five dimensions. They also showed higher scores in the Systemic Sclerosis Health Assessment Questionnaire items related to hand function such as, dress and self-care (p < 0.013), eat (p < 0.013) and grip (p < 0.03), and higher Visual Analogic Scale scores for pain (p < 0.013), trouble related with Raynaud's Phenomenon (p < 0.001) and sense of severity (p < 0.004). Impact on daily activities was significantly higher in patients with DUs (p = 0.002), with a non-significant trend to experience higher impact on work productivity (p = 0.07). A high correlation was found between DUs patients and physicians opinion on the impact of DUs (daily life: Pearson R = 0.86; work productivity: Pearson R = 0.87). Study findings show an impaired hand function and increased disability for daily life activities and work productivity in SSc patients with DUs compared with patients without DUs in Spanish population.

Published
2019

43. Tocilizumab in Giant Cell Arteritis: The Safest and Most Effective Initial Dose of Prednisone

Author

Calderon-Goercke, M, Loricera, J, Prieto-Pena, D, Castaneda, S, Caceres, VA, Villa, I, Humbria, A, Moriano, C, Romero-Yuste, S, Narvaez, J, Gomez-Arango, C, Pampin, EP, Melero, R, Becerra-Fernandez, E, Revenga, M, Alvarez-Rivas, N, Galisteo, C, Sivera, F, Olive-Marques, A, del Buergo, MA, Marena-Rojas, L, Fernandez-Lopez, C, Navarro, F, Raya, E, Galindez-Agirregoikoa, E, Arca, B, Solans-Laque, R, Conesa, A, Hidalgo, C, Vazquez, C, Roman-Ivorra, JA, Lluch, P, Manrique, S, Vela, P, de Miguel, E, Torres-Martin, C, Nieto, JC, Ordas-Calvo, C, Salgado-Perez, E, Luna-Gomez, C, De Miera, FJTS, Fernandez-Llanio, N, Garcia, A, Aurrecoechea, E, Ortego, N, Ortiz-Sanjuan, F, Corteguera, M, Hernandez, JL, Gonzalez-Gay, MA, and Blanco, R

Published
2019

44. BIOLOGICAL THERAPYIN NEUROBEHCET. MULTICENTER STUDY OF 29 PATIENTS

Author

Martin-Varillas, JL, Gonzalez-Mazon, I, Atienza-Mateo, B, Calderon-Goercke, M, Prieto-Pena, D, Bilbao, LS, Calvo-Rio, V, Castaneda, S, Vicente, E, Maiz, O, Moriano, C, Alvarez, ED, Sanchez, JLA, Beltran, CD, Martinez, ML, Narvaez, J, Calvo, AR, Sivera, F, Raya, E, Ortego, N, Callejas-Rubio, JL, Brandy-Garcia, A, Olive, A, Fernandez, S, de la Torre, RG, Torre-Salaberri, I, Sanchez, J, Urruticoechea-Arana, A, Salgado-Perez, E, Melero, R, Gonzalez, OM, Romero-Yuste, S, Gonzalez-Gay, MA, and Blanco, R

Published
2019

45. Response to Tocilizumab in Patients with Giant Cell Arteritis, According to Ischemic vs Systemic Symptoms

Author

Calderon-Goercke, M, Loricera, J, Prieto-Pena, D, Castaneda, S, Caceres, VA, Villa, I, Humbria, A, Moriano, C, Romero-Yuste, S, Narvaez, J, Gomez-Arango, C, Pampin, EP, Melero, R, Becerra-Fernandez, E, Revenga, M, Alvarez-Rivas, N, Galisteo, C, Sivera, F, Olive-Marques, A, del Buergo, MA, Marena-Rojas, L, Fernandez-Lopez, C, Navarro, F, Raya, E, Galindez-Agirregoikoa, E, Arca, B, Solans-Laque, R, Conesa, A, Hidalgo, C, Vazquez, C, Roman-Ivorra, JA, Lluch, P, Manrique, S, Vela, P, de Miguel, E, Torres-Martin, C, Nieto, JC, Ordas-Calvo, C, Salgado-Perez, E, Luna-Gomez, C, De Miera, FJTS, Fernandez-Llanio, N, Garcia, A, Larena, C, Varela-Garcia, M, Dos Santos, R, Ortego, N, Hernandez, JL, Gonzalez-Gay, MA, and Blanco, R

Published
2019

46. AB0669 Maintenance treatment with adalimumab in refractory uveitis due to behÇet’s disease: optimised vs non-optimised group

Author

Martín-Varillas, J.L., primary, Calvo-Río, V., additional, Beltrán, E., additional, Sánchez, J., additional, Mesquida, M., additional, Adán, A., additional, Hernández, M.V., additional, Hernández, M., additional, Valls, E., additional, Martínez, L., additional, Sellas, A., additional, Cordero, M., additional, Díaz, M., additional, Gallego, R., additional, Salom, D., additional, Ortego, N., additional, García, J.L., additional, Callejas, J.L., additional, Herreras, J.M., additional, García, A.M., additional, Maíz, O., additional, Blanco, A., additional, Torre, I., additional, Díaz, D., additional, Pato, E., additional, Aurrecoechea, E., additional, Caracuel, M.A., additional, Gamero, F., additional, Minguez, E., additional, Carrasco, C., additional, Olive, A., additional, Vázquez, J., additional, Ruiz, O., additional, Manero, J., additional, Muñoz, S., additional, Gandía, M., additional, Rubio, E., additional, Toyos, F.J., additional, López, F.J., additional, Nolla, J.M., additional, Revenga, M., additional, González-Vela, C., additional, Loricera, J., additional, Atienza-Mateo, B., additional, Demetrio-Pablo, R., additional, Hernández, J.L., additional, González-Gay, M.A., additional, and Blanco, R., additional

Published
2018
Full Text
View/download PDF

47. SAT0622 High dose intravenous methylprednisolone induces rapid improvement in severe uveitis: a multicenter study of 129 patients

Author

Vegas-Revenga, N., primary, Calvo-Río, V., additional, González-Mazón, I., additional, Sánchez-Bilbao, L., additional, Beltrán, E., additional, Follonosa, A., additional, Maíz, O., additional, Blanco, A., additional, Cordero, M., additional, Ortego, N., additional, Torre, I., additional, Hernández, F., additional, Muñoz, S., additional, Esteban, M., additional, Diaz-Llopis, M., additional, Cañal, J., additional, Ventosa, J.A., additional, Demetrio, R., additional, Agudo, M., additional, Dominguez-Casas, L., additional, González-Gay, M.A., additional, and Blanco, R., additional

Published
2018
Full Text
View/download PDF

48. THU0439 Tocilizumab in giant cell arteritis. national multicenter study of 134 patients of clinical practice

Author

Prieto-Peña, D., primary, Loricera, J., additional, Martín-V, J., additional, Calderón-G, M., additional, Aldasoro, V., additional, Varela-G, M., additional, Ibánez-B, R., additional, Villa, I., additional, Aurrecoechea, E., additional, Castañeda, S., additional, Humbría, A., additional, Díez, E., additional, Moriano, C., additional, Romero-Y, S., additional, Narváez, J., additional, Gómez-A, C., additional, Mera, A., additional, Pérez-P, E., additional, Dos Santos, R., additional, Barbazán, C., additional, Melero, R., additional, Becerra-F, E., additional, García, Á., additional, Revenga, M., additional, Larena, C., additional, Miguel, E., additional, Álvarez-R, N., additional, Galisteo, C., additional, Sivera, F., additional, Olivé-M, A., additional, Prior, A., additional, Álvarez, M., additional, Marena-R, L., additional, Fernández-L, C., additional, Navarro, F., additional, Raya, E., additional, Ortego, N., additional, Galíndez-A, E., additional, Arca, B., additional, Fernández, S., additional, Solans-L, R., additional, Conesa, A., additional, Hidalgo, C., additional, Vázquez, C., additional, Román-I, J., additional, Ortiz-S, F., additional, Lluch, P., additional, Manrique-A, S., additional, Vela, P., additional, Torres-M, C., additional, Nieto, J., additional, Ordas-C, C., additional, Salgado-P, E., additional, Gómez, C., additional, Toyos, J., additional, Hernández, I., additional, Maceiras-P, F., additional, Fernández-L, N., additional, García, A., additional, Palmou-F, N., additional, Calvo-R, V., additional, González-V, C., additional, Domínguez-C, L., additional, Corrales, A., additional, Hernández, J., additional, González-Gay, M., additional, and Blanco, R., additional

Published
2018
Full Text
View/download PDF

49. FRI0500 Extracranial vascular affection in giant cell arteritis

Author

Martín-Varillas, J.L., primary, Loricera, J., additional, Prieto-Peña, D., additional, Narváez, J., additional, Aurrecoechea, E., additional, Villa, I., additional, Castañeda, S., additional, Gómez-Arango, C., additional, Mera, A., additional, Pérez-Pampín, E., additional, Aldasoro, V., additional, Álvarez-Rivas, N., additional, Fernández-Llanio, N., additional, Álvarez de Buergo, M., additional, Marena-Rojas, L., additional, Sivera, F., additional, Galíndez-Aguirregoikoa, E., additional, Solans-Laqué, R., additional, Romero-Yuste, S., additional, Ortego, N., additional, Revenga, M., additional, Larena, C., additional, Hernández, Í., additional, Maceiras-Pan, F.J., additional, Salgado, E., additional, Fernández, S., additional, Calderón-Goercke, M., additional, Martínez-Rodríguez, I., additional, Banzo, J.I., additional, Calvo-Río, V., additional, Atienza-Mateo, B., additional, Palmou-Fontana, N., additional, González-Vela, C., additional, Hernández, J.L., additional, González-Gay, M.A., additional, and Blanco, R., additional

Published
2018
Full Text
View/download PDF

50. AB0670 Short and long-term treatment with infliximab in retinal vasculitis of behÇet’s disease. multicenter study of 72 patients

Author

Martín-Varillas, J.L., primary, Calvo-Río, V., additional, Demetrio-Pablo, R., additional, Atienza-Mateo, B., additional, Loricera, J., additional, Hernández, M.V., additional, Adán, A., additional, Mesquida, M., additional, Peiteado, D., additional, Pato, E., additional, Díaz, D., additional, Martínez, L., additional, Valls, E., additional, Caracuel, M.A., additional, García, A.M., additional, Herreras, J.M., additional, Cordero, M., additional, Montilla, C., additional, Fonollosa, A., additional, Atanes, A., additional, Hernández, F.F., additional, Torre, I., additional, Maíz, O., additional, Blanco, A., additional, Espartero, C., additional, Ortego, N., additional, Raya, E., additional, Gandía, M., additional, López, F.J., additional, Alcalde, M., additional, Fernández, C., additional, Ruiz, Ó., additional, Jiménez, F., additional, Almodovar, R., additional, Carrasco, C., additional, Linares, L., additional, Romero, F., additional, Insua, S., additional, González, S., additional, Hernández, M., additional, Beltrán, E., additional, Cruz, J., additional, Aurrecoechea, E., additional, González-Gay, M.A., additional, and Blanco, R., additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results